Search results
The National Institute of Allergy and Infectious Diseases ( NIAID, / ˈnaɪ.æd /) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS).
Dec 19, 2023 · The National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. Following is a brief description of the major areas of investigation. Acquired Immunodeficiency Syndrome (AIDS).
The National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports research to understand, treat, and prevent infectious and allergic diseases.
Dec 6, 2023 · Learn more about who qualifies as a new investigator under NIH’s definition and how that status benefits you at NIAID's Information for New Investigators. NIH Versus NIAID: Locus of Review. Initial peer review is one key area where the NIH versus IC distinction matters.
Apr 16, 2021 · Develop flexible domestic and international research capacities to respond appropriately to emerging and re-emerging disease threats at home and abroad. NIAID advances the understanding, diagnosis, and treatment of many of the world’s most intractable and widespread diseases.
Apr 23, 2020 · The NIAID Strategic Plan for COVID-19 Research has four key priorities. The first involves improving fundamental knowledge of SARS-CoV-2 and COVID-19, including studies to characterize the virus and better understand how it causes infection and disease.
Global Research. The map identifies 133 countries with NIAID-funded activities in fiscal year 2022. NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases.
Feb 2, 2022 · NIAID aims to support critical basic and preclinical studies to characterize these prototype and priority pathogens, including understanding viral biology and structure, host-immune responses, mechanisms of immune evasion, disease pathogenesis and animal models of disease.
The Division of AIDS (DAIDS) was formed in 1986 to develop and implement the national research agenda to address the HIV/AIDS epidemic. Toward that end, the division supports a global research portfolio to advance biological knowledge of HIV/AIDS, its related co-infections, and co-morbidities.
Apr 21, 2023 · Develop strategies to prevent and treat immunologic, allergic, and infectious diseases. A strong clinical research component is integral to the DIR, allowing key lab discoveries to be rapidly translated into methods to prevent, diagnose, or treat disease.
